Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Safety and Feasibility of Intravenous Autologous Bone Marrow Derived Stem Cell Therapy for Patients with Acute Ischaemic Stroke: An Open-Label, Phase I Trial
Cerebrovascular Disease and Interventional Neurology
(-)
003
Authors/Disclosures
Kameshwar Prasad, MD (Rajendra Institute of Medical Sciences, Ranchi) The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Kara A. Sands, MD (University of Alabama at Birmingham, Department of Neurology) Dr. Sands has nothing to disclose.
Rohit Bhatia, MD, MBBS, DM Dr. Bhatia has nothing to disclose.
No disclosure on file
No disclosure on file
Ajay Garg Ajay Garg has nothing to disclose.
Achal K. Srivastava, MD, FAAN (AIIMS) Dr. Srivastava has nothing to disclose.
No disclosure on file
Manjari Tripathi, MD (ALL INDIA INSTITUTE OF MEDICAL SCIENCES) Dr. Tripathi has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file